NASDAQ:ACB

Aurora Cannabis (ACB) Stock Price, News & Analysis

Aurora Cannabis logo
$4.16 -0.10 (-2.23%)
Closing price 11/20/2026 03:58 PM Eastern
Extended Trading
$4.20 +0.03 (+0.72%)
As of 11/20/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Aurora Cannabis Stock (NASDAQ:ACB)

Advanced

Key Stats

Today's Range
$4.15
▼
$4.35
50-Day Range
$3.81
▼
$5.24
52-Week Range
$2.56
▼
$6.36
Volume
899,951 shs
Average Volume
1.87 million shs
Market Capitalization
$273.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

Aurora Cannabis is a Canadian cannabis company headquartered in Edmonton, Alberta. Founded in 2006, it grows, processes and sells cannabis products, with a primary focus on medical cannabis and additional sales in Canada’s adult-use market.

The company’s products include dried cannabis flower, oils and other cannabis-based formats. Aurora markets products under brands such as Aurora, MedReleaf and San Rafael ’71, and supplies medical cannabis to patients and customers in Canada and international markets, including parts of Europe and Australia.

Aurora has expanded through acquisitions, including the purchases of CanniMed Therapeutics and MedReleaf in 2018. Miguel Martin has served as the company’s chief executive officer since 2020.

AI Generated. May Contain Errors.

Aurora Cannabis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
9th Percentile Overall Score

ACB MarketRank™: 
0.437075065905 of 5 stars

Aurora Cannabis scored higher than 9% of companies evaluated by MarketBeat, and ranked 834th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Aurora Cannabis has received a consensus rating of Reduce. The company's average rating score is 1.80, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and 2 sell ratings.

  • Amount of Analyst Coverage

    Aurora Cannabis has only been the subject of 3 research reports in the past 90 days.

  • Read more about Aurora Cannabis' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Aurora Cannabis is -4.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Aurora Cannabis is -4.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Aurora Cannabis has a P/B Ratio of 0.74. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Aurora Cannabis' valuation and earnings.
  • Percentage of Shares Shorted

    12.81% of the float of Aurora Cannabis has been sold short.
  • Short Interest Ratio / Days to Cover

    Aurora Cannabis has a short interest ratio ("days to cover") of 12.75, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Aurora Cannabis has recently increased by 2.72%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Aurora Cannabis does not currently pay a dividend.

  • Dividend Growth

    Aurora Cannabis does not have a long track record of dividend growth.

  • News Sentiment

    Aurora Cannabis has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Aurora Cannabis this week, compared to 5 articles on an average week.
  • Search Interest

    Only 1 people have searched for ACB on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    14 people have added Aurora Cannabis to their MarketBeat watchlist in the last 30 days. This is an increase of 133% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Aurora Cannabis insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.01% of the stock of Aurora Cannabis is held by insiders.

  • Percentage Held by Institutions

    47.63% of the stock of Aurora Cannabis is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Aurora Cannabis' insider trading history.
Receive ACB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ACB Stock News Headlines

432 miles southeast of Washington, DC…
Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip maker for nearly four decades, including AMD, Intel, NVIDIA, Samsung and Taiwan Semiconductor. Washington is set to declare it a national strategic resource and ban its export. Apple, NVIDIA and Amazon have committed over $2 trillion, and Morgan Stanley estimates a $10 trillion economic boom. One small U.S. mining company sits at the center of it.tc pixel
Bronze bull and bear statues face off in an urban financial district at sunset.
MarketBeat Week in Review – 10/19 - 10/23 (ACB)
A market sell-off spread beyond tech as oil prices surged and AI concerns grew. MarketBeat analysts recap the week's top stories on earnings, from Halliburton to Meta Platforms and General Motors.
See More Headlines

ACB Stock Analysis - Frequently Asked Questions

Aurora Cannabis' stock was trading at $4.22 at the start of the year. Since then, ACB stock has decreased by 1.3% and is now trading at $4.1650.

Aurora Cannabis Inc. (NASDAQ:ACB) released its quarterly earnings data on Wednesday, August, 5th. The company reported $0.04 earnings per share for the quarter, beating the consensus estimate of ($0.13) by $0.17. The business earned $47.62 million during the quarter, compared to the consensus estimate of $47.45 million. Aurora Cannabis had a positive trailing twelve-month return on equity of 3.72% and a negative net margin of 23.70%.
Read the conference call transcript
.

Shares of Aurora Cannabis reverse split on Tuesday, February 20th 2024.The 1-10 reverse split was announced on Tuesday, February 20th 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Aurora Cannabis subsidiaries include Reliva LLC, Whistler Medical Marijuana Corporation, ICC Labs Inc., Anandia Labs Inc, MedReleaf Corp., CanniMed Therapeutics Inc., Larssen Ltd, and more.

Top institutional shareholders of Aurora Cannabis include K2 Principal Fund L.P. (1.97%), Goldman Sachs Group Inc. (1.93%), Toronto Dominion Bank (0.09%) and JW Asset Management LLC (0.06%).

Shares of ACB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aurora Cannabis investors own include Canopy Growth (CGC), Cronos Group (CRON), Tilray Brands (TLRY), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA) and NIO (NIO).

Company Calendar

Last Earnings
8/05/2026
Today
11/21/2026
Next Earnings (Estimated)
2/03/2027
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:ACB
Previous Symbol
NYSE:ACB
CIK
1683541
Fax
N/A
Employees
1,028
Year Founded
2006

Profitability

EPS (Trailing Twelve Months)
($0.98)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$88.13 million
Net Margins
-23.70%
Pretax Margin
-3.81%
Return on Equity
3.72%
Return on Assets
3.03%

Debt

Debt-to-Equity Ratio
0.03
Current Ratio
5.00
Quick Ratio
2.60

Sales & Book Value

Annual Sales
$247.82 million
Price / Sales
1.10
Cash Flow
$0.63 per share
Price / Cash Flow
6.57
Book Value
$5.64 per share
Price / Book
0.74

Miscellaneous

Outstanding Shares
65,720,000
Free Float
65,718,000
Market Cap
$273.72 million
Optionable
Optionable
Beta
0.65

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NASDAQ:ACB) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners